Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Invitae Corp (NVTA)

Invitae Corp (NVTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Invitae Announces Pricing of Public Offering of Common Stock

Invitae Corporation (NYSE: NVTA) today announced the pricing of an underwritten public offering of 17,777,778 shares of its common stock at a price to the public of $9.00 per share. All of the shares are...

NVTA : 12.62 (-0.24%)
Invitae Announces Proposed Public Offering of Common Stock

Invitae Corporation (NYSE: NVTA) today announced that it has commenced an underwritten public offering of $125.0 million of shares of its common stock, before deducting underwriting discounts and commissions...

NVTA : 12.62 (-0.24%)
Invitae (NVTA) Gains But Lags Market: What You Should Know

In the latest trading session, Invitae (NVTA) closed at $14.19, marking a +0.71% move from the previous day.

NVTA : 12.62 (-0.24%)
Dow, S&P Have First Back-to-Back Gains in Over a Month

Dow, S&P Have First Back-to-Back Gains in Over a Month

LULU : 181.25 (-2.29%)
TXRH : 35.26 (+2.29%)
RH : 86.19 (-3.28%)
AYX : 81.74 (-2.11%)
NVTA : 12.62 (-0.24%)
SATS : 29.30 (-2.33%)
MAXR : 9.54 (+2.91%)
Invitae (NVTA) Stock Moves -0.59%: What You Should Know

Invitae (NVTA) closed at $10.09 in the latest trading session, marking a -0.59% move from the prior day.

NVTA : 12.62 (-0.24%)
Invitae and Muscular Dystrophy Association (MDA) Expand Access to No-Charge Genetic Testing in the U.S. and Canada

Invitae (NYSE: NVTA), a leading medical genetics company today announced its partnership with the Muscular Dystrophy Association (MDA) to offer sponsored, no-charge genetic testing to patients through...

NVTA : 12.62 (-0.24%)
Look for Shares of Invitae Corp to Potentially Rebound after Yesterday's 2.42% Sell Off

Invitae Corp (NYSE:NVTA) traded in a range yesterday that spanned from a low of $8.52 to a high of $10.36. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $10.22...

NVTA : 12.62 (-0.24%)
Is the Options Market Predicting a Spike in Invitae (NVTA) Stock?

Investors need to pay close attention to Invitae (NVTA) stock based on the movements in the options market lately.

NVTA : 12.62 (-0.24%)
Dow Drops 10% as Market Looks for Help from Government

Dow Drops 10% as Market Looks for Help from Government

UGA : 11.97 (+5.00%)
WOOD : 44.61 (-3.26%)
PALL : 205.84 (-0.84%)
DBX : 17.96 (-1.48%)
WWE : 34.13 (-1.50%)
ROG : 82.99 (-5.71%)
SPY : 248.19 (-1.45%)
UDOW : 36.72 (-4.67%)
MSFT : 153.83 (-0.92%)
CME : 173.74 (+3.07%)
TXRH : 35.26 (+2.29%)
CURE : 37.08 (-2.70%)
ALGN : 154.20 (+1.40%)
EXAS : 55.75 (-3.21%)
TQQQ : 42.42 (-4.03%)
SPXL : 23.11 (-4.19%)
SVXY : 31.11 (+2.13%)
NVTA : 12.62 (-0.24%)
MO : 37.41 (+3.29%)
TAP : 41.01 (+2.52%)
Invitae Acquires Diploid, Maker of Artificial-Intelligence Engine to Enable Clinical Diagnosis Using Whole Genome Sequencing in Minutes

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, announced today the acquisition of Diploid, a privately held Belgian company that developed Moon, artificial intelligence (A.I.) software...

NVTA : 12.62 (-0.24%)
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced it has entered into definitive agreements to acquire YouScript, a privately held clinical decision support and analytics...

NVTA : 12.62 (-0.24%)
Invitae to Present at Oppenheimer's 30th Annual Healthcare Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co founder and chief executive officer of Invitae, will present at Oppenheimer's 30th Annual Healthcare...

NVTA : 12.62 (-0.24%)
Invitae to Present at the Cowen and Company's 40th Annual Health Care Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co-founder and chief executive officer of Invitae, will present at the Cowen and Company's 40th Annual...

NVTA : 12.62 (-0.24%)
Where the Bulls Roam: TSLA, ILMN, SQ, NVTA, TTD

Do you know which investment whales were buying and selling your favorite stocks before the big rally to new highs?

ILMN : 263.50 (-3.48%)
TSLA : 480.01 (+5.62%)
SQ : 43.72 (-4.71%)
NVTA : 12.62 (-0.24%)
TTD : 160.39 (-2.66%)
Look for Shares of Invitae Corp to Potentially Rebound after Yesterday's 10.84% Sell Off

Invitae Corp (NYSE:NVTA) traded in a range yesterday that spanned from a low of $23.30 to a high of $24.80. Yesterday, the shares fell 10.8%, which took the trading range below the 3-day low of $26.14...

NVTA : 12.62 (-0.24%)
Invitae to Present at the 9th Annual SVB Leerink Global Healthcare Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co-founder and chief executive officer of Invitae, will present at the 9th Annual SVB Leerink Global...

NVTA : 12.62 (-0.24%)
Invitae: 4Q Earnings Snapshot

SAN FRANCISCO (AP) _ Invitae Corp. (NVTA) on Wednesday reported a loss of $76.9 million in its fourth quarter.

NVTA : 12.62 (-0.24%)
Invitae Reports $216.8 Million in Annual Revenue Driven by More Than 482,000 Samples in 2019

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the fourth quarter and full year ended December 31, 2019.

NVTA : 12.62 (-0.24%)
Bull of the Day: Guardant Health (GH)

Bull of the Day: Guardant Health (GH)

UNH : 229.49 (-4.55%)
NVTA : 12.62 (-0.24%)
GH : 60.49 (-7.11%)
EXAS : 55.75 (-3.21%)
BIIB : 300.51 (-1.30%)
AMGN : 205.41 (-1.66%)
Invitae Corp Up 43.4% Since SmarTrend Uptrend Call (NVTA)

SmarTrend identified an Uptrend for Invitae Corp (NYSE:NVTA) on January 15th, 2020 at $18.90. In approximately 1 month, Invitae Corp has returned 43.40% as of today's recent price of $27.09.

NVTA : 12.62 (-0.24%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS -2.23 , SEDG -2.49 , THC -1.30 , TER -0.57 , LITE -3.30
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar